ortho-evra and Varicose-Ulcer

ortho-evra has been researched along with Varicose-Ulcer* in 2 studies

Other Studies

2 other study(ies) available for ortho-evra and Varicose-Ulcer

ArticleYear
UK primary care survey of venous leg ulceration management and referral - Post-EVRA trial.
    Phlebology, 2021, Volume: 36, Issue:1

    Determine standards of referral and management of patients with venous leg ulceration in primary care after the release of the EVRA (A Randomized Trial of Early Endovenous Ablation in Venous Ulceration) study results.. An online questionnaire was disseminated over four months to professionals working within primary care.. The survey received 643 responses. Of respondents, 90 (14%) had heard of the EVRA trial and 51 (8%) were familiar with the results. Of those who answered the following questions, 410 (69.1%) stated that referral to a vascular specialist must be made by the General Practitioner and 13 (2.2%) reported that they would always refer patients for secondary care assessment before the publication of EVRA. Considering the EVRA results, 128 (29%) reported that they would change practice regarding referral and would experience no barriers and 198 (45%) reported that they would like to refer earlier but is not their decision. Barriers to changing practice included local referral policies, training and time restrictions, 266 (59%) had heard of the NICE guideline (CG168) and 194 (43%) were aware of the recommendations for referral to a vascular service within two weeks for patients with an open or healed ulcer.. There is a considerable variation in local referral pathways for venous leg ulceration, and despite clinicians wanting to refer promptly, many primary care professionals are unable to. Unfortunately, the EVRA study alone may not change the overall practice, and work is needed to overcome barriers faced by primary care professionals.

    Topics: Drug Combinations; Ethinyl Estradiol; Humans; Leg; Leg Ulcer; Norgestrel; Primary Health Care; Referral and Consultation; Surveys and Questionnaires; United Kingdom; Varicose Ulcer; Wound Healing

2021
The management of venous leg ulceration post the EVRA (early venous reflux ablation) ulcer trial: Management of venous ulceration post EVRA.
    Phlebology, 2021, Volume: 36, Issue:3

    This survey study evaluates current management strategies for venous ulceration and the impacts of the EVRA trial results.. An online survey was disseminated to approximately 15000 clinicians, through 12 vascular societies in 2018. Survey themes included: referral times, treatment times and strategies, knowledge of the EVRA trial and service barriers to managing venous ulceration. Data analysis was performed using Microsoft Excel and SPSS.. 664 responses were received from 78 countries. Respondents were predominantly European (55%) and North American (23%) vascular surgeons (74%). Responses varied between different countries. The median vascular clinic referral time was 6 weeks and time to be seen in clinic was 2 weeks. This was significantly higher in the UK (p ≤ 0.02). 77% of respondents performed surgical/endovenous interventions prior to ulcer healing, the median time to intervention was 4 weeks. 31% of participants changed their practice following EVRA. Frequently encountered barriers to implementing change were a lack of operating space/time (18%).. Venous ulcers are not managed as quickly as they should be. An evaluation of local resource requirements should be performed to improve service provision for venous ulceration. When interpreting the results of this survey consideration should be given to the response rate.

    Topics: Drug Combinations; Ethinyl Estradiol; Humans; Leg; Leg Ulcer; Norgestrel; Ulcer; Varicose Ulcer; Wound Healing

2021